EYPT - EyePoint Pharmaceuticals, Inc.

QQQ $ 479.76 $ 5.15 (1.08 %)

DIA $ 411.97 $ 4.35 (1.07 %)

SPY $ 562.00 $ 5.91 (1.06 %)

TLT $ 98.37 $ 0.64 (0.65 %)

GLD $ 231.99 $ 2.65 (1.16 %)

Previous Close

$ 9.19

Open

$ 9.18

Bid

$ 9.19 x 100

Ask

$ 9.21 x 400

Day's Range

$ 9.00 - $ 9.56

52 Week Range

$ 5.67 - $ 30.99

Volume

539,635

Average Volume

Market Cap

491.83M

Beta (5Y Monthly)

$ 1.25

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-08-2024	06-30-2024	10-Q
2	05-09-2024	03-31-2024	10-Q
3	03-08-2024	12-31-2023	10-K
4	11-03-2023	09-30-2023	10-Q
5	08-04-2023	06-30-2023	10-Q
6	05-04-2023	03-31-2023	10-Q
7	03-10-2023	12-31-2022	10-K
8	11-04-2022	09-30-2022	10-Q
9	08-05-2022	06-30-2022	10-Q
10	05-06-2022	03-31-2022	10-Q
11	03-12-2022	12-31-2021	10-K
12	11-05-2021	09-30-2021	10-Q
13	08-06-2021	06-30-2021	10-Q
14	05-05-2021	03-31-2021	10-Q
15	03-12-2021	12-31-2020	10-K
16	11-06-2020	09-30-2020	10-Q
17	08-05-2020	06-30-2020	10-Q
18	05-08-2020	03-31-2020	10-Q
19	03-16-2020	12-31-2019	10-K
20	11-07-2019	09-30-2019	10-Q
21	08-07-2019	06-30-2019	10-Q
22	05-10-2019	03-31-2019	10-Q
23	11-09-2018	09-30-2018	10-Q
24	09-18-2018	06-30-2018	10-K
25	05-10-2018	03-31-2018	10-Q
26	02-08-2018	12-31-2017	10-Q
27	11-08-2017	09-30-2017	10-Q
28	09-13-2017	06-30-2017	10-K
29	05-08-2017	03-31-2017	10-Q
30	02-09-2017	12-31-2016	10-Q
31	11-08-2016	09-30-2016	10-Q
32	09-13-2016	06-30-2016	10-K
33	05-06-2016	03-31-2016	10-Q
34	02-09-2016	12-31-2015	10-Q
35	11-06-2015	09-30-2015	10-Q
36	09-10-2015	06-30-2015	10-K
37	05-08-2015	03-31-2015	10-Q
38	02-06-2015	12-31-2014	10-Q
39	11-07-2014	09-30-2014	10-Q
40	09-11-2014	06-30-2014	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

EyePoint Pharmaceuticals Stock: A Deep Div...
08/13/2024 13:00:40

JP Morgan Maintains Overweight on EyePoint...
08/13/2024 12:33:13

JP Morgan analyst Tessa Romero maintains EyePoint Pharmaceuticals (NASDAQ:EYPT) with a Overweight and lowers the price targe...

EyePoint Pharmaceuticals' Cash And Investm...
08/07/2024 11:34:39

EyePoint Pharmaceuticals Q2 2024 GAAP EPS ...
08/07/2024 11:33:31

Eyepoint Pharmaceuticals Granted U.S. Pate...
07/23/2024 14:14:43

https://ppubs.uspto.gov/dirsearch-public/print/downloadPdf/20240238387

why-asp-isotopes-shares-are-trading-lower-by-9-here-are-other-stocks-moving-in-fridays-mid-day-session

Why ASP Isotopes Shares Are Trading Lower ...
07/12/2024 17:14:56

bank-of-new-york-mellon-posts-upbeat-earnings-joins-archer-aviation-rivian-automotive-and-other-big-stocks-moving-higher-on-friday

Bank of New York Mellon Posts Upbeat Earni...
07/12/2024 14:27:17

Chardan Capital Maintains Buy on EyePoint ...
06/28/2024 12:31:13

Chardan Capital analyst Daniil Gataulin maintains EyePoint Pharmaceuticals (NASDAQ:EYPT) with a Buy and maintains $28 price ...

HC Wainwright & Co. Reiterates Buy on EyeP...
06/27/2024 10:16:18

HC Wainwright & Co. analyst Yi Chen reiterates EyePoint Pharmaceuticals (NASDAQ:EYPT) with a Buy and maintains $30 price...

EyePoint Pharmaceuticals To Highlight DURA...
06/26/2024 12:06:00

– Phase 3 trial design for the LUGANO and LUCIA pivotal non-inferiority trials of DURAVYU in wet AMD based on positive EOP2 mee...

Cantor Fitzgerald Reiterates Overweight on...
06/20/2024 17:34:14

Cantor Fitzgerald analyst Jennifer Kim reiterates EyePoint Pharmaceuticals (NASDAQ:EYPT) with a Overweight.

JP Morgan Maintains Overweight on EyePoint...
06/04/2024 13:17:52

JP Morgan analyst Tessa Romero maintains EyePoint Pharmaceuticals (NASDAQ:EYPT) with a Overweight and lowers the price targe...

crocs-to-rally-around-19-here-are-10-top-analyst-forecasts-for-monday

Crocs To Rally Around 19%? Here Are 10 Top...
05/13/2024 12:31:26

HC Wainwright & Co. Maintains Buy on EyePo...
05/13/2024 10:57:47

HC Wainwright & Co. analyst Yi Chen maintains EyePoint Pharmaceuticals (NASDAQ:EYPT) with a Buy and lowers the price tar...

EyePoint Pharmaceuticals' Q1 Cash And Inve...
05/08/2024 11:18:37

EyePoint Pharmaceuticals Q1 2024 GAAP EPS ...
05/08/2024 11:17:32

Baird Maintains Outperform on EyePoint Pha...
05/08/2024 11:02:17

Baird maintains EyePoint Pharmaceuticals (NASDAQ:EYPT) with a Outperform and lowers the price target from $46 to $38.

flywire-reports-q1-loss-joins-zoominfo-inspire-medical-systems-and-other-big-stocks-moving-lower-in-wednesdays-pre-market-session

Flywire Reports Q1 Loss, Joins ZoomInfo, I...
05/08/2024 10:05:47

Deep Dive Into EyePoint Pharmaceuticals St...
05/07/2024 17:00:17

Chardan Capital Maintains Buy on EyePoint ...
05/07/2024 12:51:15

Chardan Capital analyst Daniil Gataulin maintains EyePoint Pharmaceuticals (NASDAQ:EYPT) with a Buy and lowers the price tar...